Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Morphology to Mechanism: Cryo-Electron Microscopy Insights into Lipid Nanoparticles for RNA Delivery.

ACS nano·2026
Same author

Engineering Nanoemulsions to Maximize NIR-II Fluorescence and Preserve Photothermal Performance of a Novel Boron Difluoride Formazanate Dye.

Angewandte Chemie (International ed. in English)·2026
Same author

Advancing regenerative medicine with RNA nanotechnology for chronic and end organ diseases.

Communications medicine·2026
Same author

Human and mouse long noncoding RNAs reengineered for exogenous delivery reduce LPS-induced inflammation in human macrophages and mice.

Science signaling·2026
Same author

Cancer Cells Degrade the Nanoparticle Protein Corona for Biosynthesis.

Journal of the American Chemical Society·2026
Same author

Structural Change of ApoE-Lipid Nanoparticles Alters Receptor-Mediated Endocytosis and Induces Endosomal Disruption.

Journal of the American Chemical Society·2026

Related Experiment Video

Updated: Dec 12, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.0K

The dose threshold for nanoparticle tumour delivery.

Ben Ouyang1,2,3, Wilson Poon2,3, Yi-Nan Zhang2,3

  • 1MD/PhD Program, University of Toronto, Toronto, Ontario, Canada.

Nature Materials
|August 12, 2020
PubMed
Summary

A study found that administering over one trillion nanoparticles in mice significantly enhances nanoparticle delivery to solid tumors. This high-dose strategy overcomes limitations, improving cancer treatment efficacy.

More Related Videos

Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.4K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.3K

Related Experiment Videos

Last Updated: Dec 12, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.0K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.4K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.3K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Research

Background:

  • Nanoparticle delivery to solid tumors has remained inefficient, with median injected doses around 0.7% over the last decade.
  • Previous efforts in nanoparticle design and delivery strategies have only marginally improved tumor targeting.

Purpose of the Study:

  • To identify a strategy for significantly improving nanoparticle delivery efficiency to solid tumors.
  • To investigate the impact of high-dose nanoparticle administration on tumor targeting and therapeutic efficacy.

Main Methods:

  • Administering a high dose of nanoparticles (1 trillion) in mouse models.
  • Evaluating nanoparticle circulation time, liver clearance, and Kupffer cell uptake.
  • Assessing nanoparticle accumulation within tumors and distribution to tumor cells.
  • Comparing the therapeutic efficacy of nanoparticle treatments at different doses.

Main Results:

  • A dose threshold of 1 trillion nanoparticles was identified, significantly increasing tumor delivery efficiency up to 12%.
  • High-dose administration overwhelmed Kupffer cell uptake, reduced liver clearance, and prolonged circulation.
  • This approach led to nanoparticle delivery to 93% of cells within tumors.
  • The therapeutic efficacy of existing treatments like Caelyx/Doxil was improved.

Conclusions:

  • Exceeding a specific high dose threshold is critical for enhancing nanoparticle delivery to solid tumors.
  • This finding offers a simple yet potent principle for optimizing nanoparticle-based cancer therapies.
  • The results have significant implications for the clinical translation of nanoparticle drug delivery systems.